Loading clinical trials...

Rollover Study of VX-770 in Cystic Fibrosis Subjects | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT01117012

Rollover Study of VX-770 in Cystic Fibrosis Subjects

The primary objective of the study was to evaluate the safety of long-term VX-770 treatment in participants with cystic fibrosis (CF). The secondary objective of the study was to evaluate the efficacy...

Lead sponsor: Vertex Pharmaceuticals Incorporated•36 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Natural History of Noncirrhotic Portal Hypertension

NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more

RECRUITING

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis

RECRUITINGPhase 2

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis

RECRUITINGPhase 1

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NCT06154447 · Cystic Fibrosis

RECRUITINGPhase 3

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

NCT05422222 · Cystic Fibrosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 7, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment192

Start dateJul 2010

Last updatedJul 7, 2015

Condition

Cystic Fibrosis

Locations shown

Birmingham, Alabama

Oakland, California

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 7, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions